The global monoclonal antibodies market is estimated to grow at a CAGR of 8.6% during the forecast period. The increasing prevalence of cancer and auto-immune diseases and increasing research on monoclonal antibodies are some crucial factors accelerating market growth. There are more than 80 autoimmune diseases and some of them are well known, including multiple sclerosis, type 1 diabetes, rheumatoid arthritis, and lupus, while others are difficult and rare to diagnose. National Institutes of Health (NIH) estimates that auto-immune diseases affect over 24 million people in the US and a further eight million people have autoantibodies, blood molecules which show an individual’s possibility of developing an autoimmune disease.
Request a free sample of our report on Monoclonal Antibodies Market: https://www.omrglobal.com/request-sample/monoclonal-antibodies-market
Type 1 diabetes is a kind of autoimmune disease. In type 1 diabetes, the immune system attacks and destroys the cells that produce insulin, and thereby, the pancreas are not able to produce insulin. As per the International Diabetes Federation (IDF), nearly 10% of all people suffering from diabetes have type 1 diabetes. Anti-CD3 monoclonal antibodies are a novel class of drugs that are indicated to support preserve function of beta-cell if used early in the onset of type 1 diabetes mellitus. Preserving beta-cell function might delay the requirement for exogenous insulin treatment, which in turn, minimizes the risks of low blood sugar (hypoglycemic) events that are associated with insulin treatment.
A full report of Monoclonal Antibodies Market Is available at https://www.omrglobal.com/industry-reports/monoclonal-antibodies-market
Global Monoclonal Antibodies Market Segmentation
- Infectious Diseases
- Auto-Immune Diseases
- Inflammatory Diseases
- North America
- United States
- Rest of Europe
- Rest of Asia-Pacific
- Rest of the World
- AbbVie, Inc.
- Amgen, Inc.
- AstraZeneca plc
- Aytu BioScience, Inc.
- Bayer AG
- Biocon, Ltd.
- Biogen, Inc.
- Bristol Myers Squibb Co.
- Cadila Pharmaceuticals, Ltd.
- Daiichi Sankyo Company, Ltd.
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/monoclonal-antibodies-market
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.
For More Information, Visit https://www.omrglobal.com/
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +91 780-304-0404